The tablet - orforglipron - is available in the US and could soon launch in the UK.

Data shows orforglipron could in future avoid need to take other long-term medications for diseases associated with obesity

The tablet - orforglipron - is available in the US and could soon launch in the UK.

Orforglipron works by lowering blood sugar levels, slowing food digestion and reducing appetite

Research shows sick leave among patients prescribed GLP-1 injections over nine-month period reduced by 50%